5/12
08:39 am
mxct
MaxCyte, Inc. (NASDAQ:MXCT) Q1 2024 Earnings Call Transcript [Yahoo! Finance]
Low
Report
MaxCyte, Inc. (NASDAQ:MXCT) Q1 2024 Earnings Call Transcript [Yahoo! Finance]
5/7
07:13 pm
mxct
MaxCyte, Inc. (MXCT) Reports Q1 Loss, Tops Revenue Estimates [Yahoo! Finance]
High
Report
MaxCyte, Inc. (MXCT) Reports Q1 Loss, Tops Revenue Estimates [Yahoo! Finance]
5/7
04:05 pm
mxct
MaxCyte Reports First Quarter 2024 Financial Results and Updates 2024 Guidance
High
Report
MaxCyte Reports First Quarter 2024 Financial Results and Updates 2024 Guidance
4/23
11:52 am
mxct
MaxCyte, Inc. (NASDAQ: MXCT) had its "overweight" rating re-affirmed by analysts at Stephens. They now have a $11.00 price target on the stock.
Medium
Report
MaxCyte, Inc. (NASDAQ: MXCT) had its "overweight" rating re-affirmed by analysts at Stephens. They now have a $11.00 price target on the stock.
4/17
05:09 am
mxct
We Think MaxCyte (LON:MXCT) Can Afford To Drive Business Growth [Yahoo! Finance]
Medium
Report
We Think MaxCyte (LON:MXCT) Can Afford To Drive Business Growth [Yahoo! Finance]
4/10
08:05 am
mxct
MaxCyte to Report First Quarter 2024 Financial Results on May 7, 2024
Low
Report
MaxCyte to Report First Quarter 2024 Financial Results on May 7, 2024
4/8
09:23 am
mxct
Kytopen announces appointment of industry executive Kevin Gutshall as Chief Commercial Officer [Yahoo! Finance]
Low
Report
Kytopen announces appointment of industry executive Kevin Gutshall as Chief Commercial Officer [Yahoo! Finance]
4/2
08:40 am
mxct
MaxCyte signs strategic platform license with Be Biopharma [Seeking Alpha]
Medium
Report
MaxCyte signs strategic platform license with Be Biopharma [Seeking Alpha]
5/7/2024
04:05 pm
MXCT
maxcyte, inc.
BEAT
Report
18.1%
maxcyte, inc.
3/12/2024
04:05 pm
MXCT
maxcyte, inc.
BEAT
Report
4.5%
maxcyte, inc.
11/8/2023
04:05 pm
MXCT
maxcyte, inc.
MISS
Report
-3.3%
maxcyte, inc.
8/9/2023
04:05 pm
MXCT
maxcyte, inc.
MISS
Report
-10.4%
maxcyte, inc.
5/7
05:01 pm
mxct
Form 10-Q MAXCYTE, INC. For: Mar 31
High
Report
Form 10-Q MAXCYTE, INC. For: Mar 31
5/7
04:14 pm
mxct
Form 8-K MAXCYTE, INC. For: May 07
High
Report
Form 8-K MAXCYTE, INC. For: May 07
5/1
04:20 pm
mxct
Form ARS MAXCYTE, INC. For: Dec 31
Medium
Report
Form ARS MAXCYTE, INC. For: Dec 31
4/26
05:15 pm
mxct
Form DEF 14A MAXCYTE, INC. For: Jun 11
Low
Report
Form DEF 14A MAXCYTE, INC. For: Jun 11
3/28
04:34 pm
mxct
Form 4 MAXCYTE, INC. For: Mar 26 Filed by: Johnston John Joseph
Low
Report
Form 4 MAXCYTE, INC. For: Mar 26 Filed by: Johnston John Joseph
3/25
04:36 pm
mxct
Form SC 13G MAXCYTE, INC. Filed by: INTEGRATED CORE STRATEGIES (US) LLC
Low
Report
Form SC 13G MAXCYTE, INC. Filed by: INTEGRATED CORE STRATEGIES (US) LLC
3/19
06:22 pm
mxct
Form 4 MAXCYTE, INC. For: Mar 15 Filed by: Ross Thomas M.
Low
Report
Form 4 MAXCYTE, INC. For: Mar 15 Filed by: Ross Thomas M.
3/19
06:20 pm
mxct
Form 4 MAXCYTE, INC. For: Mar 15 Filed by: Sandoval David I.
Low
Report
Form 4 MAXCYTE, INC. For: Mar 15 Filed by: Sandoval David I.
News Stats
All News
News Wires
Media Monitoring
SEC Edgar Filings
Upgrades
Downgrades
Initiated
Reiterated
Last Earnings
Last Earnings EPS
Next Earnings
Order Stats
Sub-Penny
Odd lot
Avg. bid-ask spread
Avg. bid-ask size
Shares at ask/bid
Off exchange
Main News & Impact Reports
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below:
Register